Environmental Engineering Reference
In-Depth Information
109. Stathopoulos GP, Boulikas T, Vougiouka M, Rigatos SK, Stathopoulos JG (2006) Liposomal
cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: a
phase I-II study. Oncol Rep 15(5):1201-1204
110. Mandal B, Bhattacharjee H, Mittal N, Sah H, Balabathula P, Thoma LA, Wood GC (2013)
Core-shell-type
lipid-polymer hybrid nanoparticles
as
a drug delivery platform.
Nanomedicine 9(4):474-491. doi:
10.1016/j.nano.2012.11.010
111. Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L (2011) Erythrocyte membrane-
camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad
Sci U S A 108(27). 10980-5. doi:
10.1073/pnas.1106634108
. Epub 2011 Jun 20
112. Aryal S, Hu CM, Fang RH, Dehaini D, Carpenter C, Zhang DE, Zhang L (2013) Erythrocyte
membrane-cloaked polymeric nanoparticles for controlled drug loading and release.
Nanomedicine (Lond) 8(8):1271-1280. doi:
10.2217/nnm.12.153
113. Tanaka S, Kuroda Y, Ihara F, Nishimura M, Hiasa J, Kojima N, Nishikawa Y (2014)
Vaccination with profilin encapsulated in oligomannose-coated liposomes induces significant
protective immunity against Toxoplasma gondii. Vaccine 32(16):1781-1785. doi:
10.1016/j.
114. Senchi K, Matsunaga S, Hasegawa H, Kimura H, Ryo A (2013) Development of
oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type
3. Front Microbiol 4:346. doi:
10.3389/fmicb.2013.00346
115. Kojima N, Ishii M, Kawauchi Y, Takagi H (2013) Oligomannose-coated liposome as a novel
adjuvant for the induction of cellular immune responses to control disease status. Biomed Res
Int 2013:56292. doi:
10.1155/2013/562924
116. Ishii M, Kojima N (2013) Effective stimulation of invariant natural killer T cells by
oligomannose-coated liposomes.
Int
Immunopharmacol 15(4):685-692. doi:
10.1016/j.
117. Kawakita A, Shirasaki H, Yasutomi M, Tokuriki S, Mayumi M, Naiki H, Ohshima Y (2012)
Immunotherapy with oligomannose-coated liposomes ameliorates allergic symptoms in a
murine food allergy model. Allergy 67(3):371-379
118. Ishii M, Koyama A, Iseki H, Narumi H, Yokoyama N, Kojima N (2010) Anti-allergic
potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese
cedar pollinosis in mice. Int Immunopharmacol 10(9):1041-1046. doi:
10.1016/j.intimp.
119. Kozako T, Hirata S, Shimizu Y, Satoh Y, Yoshimitsu M, White Y, Lemonnier F, Shimeno H,
Soeda S, Arima N (2011) Oligomannose-coated liposomes efficiently induce human T-cell
leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant. FEBS J 278
(8):1358-1366. doi:
10.1111/j.1742-4658.2011.08055.x
120. Wang Y, Tu S, Li R, Yang X, Liu L, Zhang Q (2010) Cholesterol succinyl chitosan anchored
liposomes: preparation, characterization, physical stability, and drug release behavior.
Nanomedicine 6(3):471-477. doi:
10.1016/j.nano.2009.09.005
121. Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J, Li C, Hou L, Zhang Q (2012) Dual-functional
liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-
targeted anticancer drug delivery. Biomaterials 33(36):9246-9258. doi:
10.1016/j.biomate
122. Cheng J, Zhu JB, Wen N, Xiong F (2006) Stability and pharmacokinetic studies of
O-palmitoyl amylopectin anchored dipyridamole liposomes. Int J Pharm 313(1-2):136-143
123. Cohen K, Emmanuel R, Kisin-Finfer E, Shabat D, Peer D (2014) Modulation of drug
resistance in ovarian adenocarcinoma using chemotherapy entrapped in hyaluronan-grafted
nanoparticle clusters. ACS Nano 8(3):2183-2195. doi:
10.1021/nn500205b
124. Banerjee A, Onyuksel H (2012) Human pancreatic polypeptide in a phospholipid-based
micellar formulation. Pharm Res 29(6):1698-1711. doi:
10.1007/s11095-012-0718-4
125. Cesur H, Rubinstein I, Pai A, Ony¨ksel H (2009) Self-associated indisulam in phospholipid-
based nanomicelles: a potential nanomedicine for cancer. Nanomedicine 5(2):178-183.
